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Background: Smoking during pregnancy is a major public health concern and an NHS priority. In 2010, 26% of UK
women smoked immediately before or during their pregnancy and 12% smoked continuously. Smoking cessation
support is provided through free at the point of use Stop Smoking Services for Pregnant women (SSSP). However,
to date, little is known of how these services provide support across England. The aim of this study was to describe
the key elements of support provided through English SSSP.
Methods: SSSP managers were invited to participate in this survey by email. Data were then collected via an
online questionnaire; one survey was completed for each SSSP. Up to four reminder emails were sent over a two
month period.
Results: 86% (121 of 141) of services completed the survey. Responding services were, on average, larger than
non-responding services in terms of the number of pregnant women setting quit dates and successfully quitting
(p < 0.01). In line with the 2010 NICE guidelines, Stop Smoking in Pregnancy and following Childbirth, one in five
SSSP identified pregnant smokers using carbon monoxide (CO) testing and refer via an opt-out pathway. All services
offered nicotine replacement therapy (NRT) to pregnant women and 87% of services also offered dual therapy NRT, i.e.
combination of a patch and short acting NRT product.. The 2010 NICE guidelines note that services should be flexible
and client-centred. Consistent with this, SSSP offer pregnant women a range of support types (median 4) including
couple/family, group (open or closed) or one-to-one. These are available in a number of locations (median 5), including
in community venues, clinics and women’s homes.
Conclusions: English Stop Smoking Services offer behavioural support and pharmacotherapy to pregnant women
motivated to quit smoking. Interventions provided are generally evidence-based and delivered in a variety of
both social and health care settings.
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Smoking during pregnancy is a major public health con-
cern. Improving health outcomes of the next generation
is particularly of current global importance during the
economic downturn since health is key to sustainable
economic development [1]. The prevalence of smoking
during pregnancy varies between countries and reflects
variations in tobacco use amongst women. In many, low
and middle income countries, smoking in pregnancy is
an emerging problem [2,3]. In developed countries, the
problem is established with the prevalence of smoking
during pregnancy reported at around 10% in Canada [4]
and Japan [5], 14% in the USA [6], 30-35% in Spain [7]
and in the UK in 2010, 12% of women smoked through-
out their pregnancy [8]. As in many high income coun-
tries, smoking prevalence during pregnancy in the UK
has decreased over the past decade [4,8,9]. However,
data from Canada and Australia show the rate of decline
is markedly less amongst women from lower socioeco-
nomic groups, compared to those from more affluent
groups [9,10].
The literature suggests that brief advice to stop smok-
ing this has little impact on cessation outcomes for
pregnant women [11,12]. More intensive psychosocial
interventions, however, have been shown to be effective
for smoking cessation during pregnancy and also in re-
ducing adverse perinatal outcomes [3]. In the UK, such
support is available to pregnant women via Stop Smoking
Services which are free at the point of use under the
National Health Service (NHS). Stop smoking services
for all smokers were originally introduced in 1999 to
provide support to all smokers who requested this. They
were the first national smoking cessation services to be
set up globally and have served as a model to those
establishing similar programmes elsewhere [13], in line
with the recommendations in Article 14 of the Framework
Convention on Tobacco Control [14].
Within the UK’s cessation services, tailored provision
for pregnant women (Stop Smoking Services for Pregnant
women; SSSP) began to be developed from 2000. An ob-
servational audit of Scottish SSSP outcomes suggested
that delivering support through services developed solely
for pregnant women may be more effective than support-
ing pregnant women through generic services, which sup-
port all smokers [15]. In 2010, the first UK guidelines
were released on how to stop smoking in pregnancy and
following childbirth [16]. These guidelines make recom-
mendations about, not only which cessation interventions
are effective for pregnant smokers but also how health
providers should try to identify and engage with pregnant
women to offer these to them. One recommendation, for
example, is that SSSP should systematically introduce into
routine care, the use of exhaled carbon monoxide to iden-
tify pregnant smokers; the guidance also suggests thatwhere CO levels indicate that women are smokers, as a
default they should be offered NHS stop smoking support.
To date, no research has been conducted to examine how
specialist smoking in pregnancy services support quit
attempts in England. We therefore conducted a national
survey to assess how SSSP are configured, how they re-
ceive and accept referrals of pregnant smokers, and how
they then deliver smoking cessation support to pregnant
women in England.
Methods
Survey design
The survey was developed in consultation with special-
ists in smoking in pregnancy, SSSP managers and policy
makers knowledgeable about SSSP. It was designed to be
completed by each SSSP manager and covered six main
areas: service configuration, identification and referral of
pregnant smokers, methods of engaging with pregnant
women, information about service users, budgets and
costs and service delivery. The online version of the
survey was designed and implemented using Qualtrics
software (Qualtrics Labs Inc., Provo, UT).
The online survey was piloted with 14 SSSP managers.
Only a minor alteration was made to the survey as a
result of this; therefore pilot responses were analysed
together with those from the final survey. All questions
in the survey related to the 12 month reporting period
from April 2010 to March 2011. A link to the online
survey was sent to all SSSP managers via email; each
respondent received a unique username to access and
complete it. Non-responders were sent up to four
reminder emails over a three month period and if there
was still no response, respondents were contacted by
telephone and offered alternative means of completing the
survey (via hard copy, electronic copy or by telephone). A
‘Thank you’ email was automatically sent after respon-
dents had submitted their online survey responses. Nine
SSSP were successfully followed up by telephone in order
to address problems with missing data.
Survey dissemination and completion
All managers and commissioners of the 141 NHS SSSP ser-
vices that were identified across England including the Isle
of Wight and the Isle of Man were contacted by email to
inform them about the survey and to obtain agreement to
complete the survey. The introduction of a ‘commissioner-
provider’ system in the English NHS has brought about the
introduction of ‘payments by results’ (PbR) services in
which payment to Stop Smoking Services are based on the
number of successful quitters [17,18]. In our survey, NHS
standard contract Stop Smoking Services that had become
PbR services, principally located in the West Midlands of
England, [19] were included but the approximately 60 pri-
vate PbR providers [19] were not.
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the Declaration of Helsinki. The results presented were
obtained as part of a service evaluation therefore ethics
approval was not required.
Data handling and analysis
All data were cleaned and analysed using Stata 11 (Stata-
Corp LP, College Station, TX). Responses are presented as
descriptive statistics in the order in which the ques-
tions appeared in the online survey. Response rate to
the budgets and costs section was low; these data will
not be presented.
Non-survey data
SSSP are required to report publicly-available service
delivery data quarterly to the English Department of
Health; this is then made [20]. Responding services were
compared with non-responding services using the following
routine data: service performance data, specifically, number
of pregnant women setting a quit date and number of preg-
nant women remaining quit at four weeks [20], index of
multiple deprivation (IMD) [21] and smoking at time of de-
livery (SaToD; available at http://www.hscic.gov.uk/search-
catalogue?productid=13675&q=title%3a%22Statistics+on
+Women%27s+Smoking+Status+at+Time+of+Delivery%
22&sort=Relevance&size=10&page=1#top). IMD provides
a deprivation score for each small area in England by using
economic, social and housing indicators to identify the de-
gree of poverty; higher IMD scores indicate higher levels of
deprivation [21]. Self-reported and carbon monoxide (CO)
validated quit rates were estimated from service perform-
ance data [20] as the proportion of pregnant women setting
a quit date who remained quit at four weeks. For non-
normally distributed variables, Wilcoxon-Mann–Whitney
tests were used to assess potential differences in the under-
lying distribution between the two groups. For normally
distributed variables, two sample t-tests were used to assess
potential differences in the means between the two groups.
Results
One hundred and forty one NHS SSSP were identified
across England and the Isles of Wight and Man. Of
these, 134 (95%) provided contact details of a represen-
tative to complete the survey (usually the service man-
ager or pregnancy lead). Responses were received from a
total of 121 SSSP (104 online, 9 telephone and 8 by hard
copy or email), representing an 86% response rate. These
services provide support to smokers in all areas of
the country; areas covered by SSSP were approximately
coterminous with those covered by the 152 Primary
Care Trusts (PCT) during the survey period. In one
large PCT area, there were two SSSP. Eight SSSP oper-
ated across two PCT areas and two SSSP operated across
three PCT areas.No significant differences were observed between
‘respondent’ and ‘non-respondent’ SSSP in terms of
area-level IMD score or self-reported quit rates (p = 0.35
and p = 0.11, respectively; Table 1). There were, however,
significantly higher numbers of pregnant women re-
ported to have set quit dates and to have successfully
quit for at least four weeks by respondent SSSP, com-
pared to non-respondent services (p < 0.01 and p < 0.01,
respectively). Similarly, the number of CO validated
quits (p = 0.003) was significantly higher in respondent
compared to non-respondent services but there was no
significant difference in CO validated quit rates (p = 0.92).
Marginal statistical evidence was observed for SaToD
being higher amongst respondents compared to non-
respondents (p = 0.05; Table 1).
Service configuration
During April 2010 to March 2011, 67 (55%) of services
provided at least some smoking cessation support to
pregnant women through a ‘specialist pregnancy service’
(Table 2). This was defined as an organisation or orga-
nised system via which smoking cessation support was
provided solely to pregnant women. However, these 67
services comprised 22 (33%) which supported pregnant
smokers exclusively through specialist pregnancy ser-
vices and 45 (67%) which provided supported via a com-
bination of these and generic Stop Smoking Service (i.e.
one which provides support to both pregnant and non-
pregnant smokers). Twelve per cent of SSSP reported
that smoking cessation support was provided to preg-
nant women on behalf of their service by midwives
employed in a local hospital maternity unit. Two ser-
vices reported that support was provided via a broad-
ranging ‘Healthy Lifestyles’ service rather than a service
solely dedicated to smoking cessation. 31% of services
reported having a specific smoking in pregnancy budget
for the 2010/11 financial year (Table 2). A total of 8
services (7%) were paid on a PbR basis (Table 2); of these
five were located in the West Midlands of England.
Seventy-six percent of SSSP had a specialist pregnancy
advisor in post, that is, an advisor who deals exclusively
with pregnant women. Of those that did not, 41% had
never had a staff member fulfilling that role (Table 2).
The most frequent category for the duration that the
specialist advisor had been in post was ‘more than three
years’ (63%). The time during which those SSSP cur-
rently without a specialist advisor in post but had previ-
ously employed one (n = 17) ranged from ‘up to six
months’ to ‘more than two years’.
Identification and referral
Just under half (45%) of SSSP reported using exhaled
CO to identify pregnant smokers as they attended ante-
natal health care. This comprised 27% that identified
Table 1 Comparing routine data for ‘respondents’ and ‘non-repondents’ to the SSSP survey
Variables Completed
survey (n = 121)
Did not complete
survey (n = 20)
Comparison
test
Test
p-value
Number set quit date
127 (80–211) 63.5 (48–92) WMW <0.01
[median (IQR)]
Number SR four-week quitters
58 (34–82) 27.8 (16–45) WMW <0.01
[median (IQR)]
Quit rate*
45.5 ± 11.5 43.0 ± 10.5 t-test 0.35
[Mean ± S.D.]
SSSP area-level IMD score
22.7 ± 8.0 25.9 ± 8.3 t-test 0.11
[Mean ± S.D.]
SaToD
14.7 ± 5.7 11.9 ± 6.6 t-test 0.05
[Mean ± S.D.]
IQR, Interquartile Range; S.D., Standard Deviation; WMW, Wilcoxon-Mann–Whitney test; SSSP, Stop Smoking Service for Pregnant women; SR, Self-Reported; IMD,
index of multiple deprivation; SaToD, smoking at time of delivery.
Of the 121 services that completed the survey, number set quit date and number four week quitters was available for 119 services and quit rate, IMD, and SaToD
was available for 120 services.
Wilcoxon-Mann–Whitney Test used to assess potential differences in the underlying distribution of non-normally distributed variables for responding services
compared to non-responding services. Two sample t-test used to assess potential differences in the mean of normally distributed variables for responding services
compared to non-responding services.
*self-reported quit rate calculated as proportion of pregnant women who set a quit date that remain quit at four weeks.
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a combination of self-report and exhaled CO. A further
39% of SSSP reported using self-reports only (Table 2).
There are currently two models via which pregnant
smokers are referred to a SSSP: opt-out referrals and opt-
in referrals. For opt-out referrals, all identified smokers
are referred unless the woman declines, whereas for
opt-in referrals, smokers are asked if they would like to
be referred. A total of 37% of SSSP reported that the
policy at their maternity unit was to refer pregnant
women identified as smokers via an opt-out referral
pathway (Table 2) with the majority (55%) of services
reporting referrals via an opt-in referral pathway, with
the remainder being unsure. Although recommended
by national guidance, just 20% of services reported
using a combination of identifying pregnant smokers
using exhaled CO and then referring those identified as
smokers using an opt-out pathway (Table 2).Engaging with pregnant women
After receiving referrals, 88% of SSSP engaged with
pregnant smokers by telephone with 58% using a spe-
cialist smoking in pregnancy advisor or manager to
make first contact with referred women (Table 2). Ad-
ministrative staff initially engaged with referred preg-
nant women in 25% of SSSP. A minority of SSSP also
used letters (6%), text messages (3%) and face-to-face
contact in the clinic (2%) to engage with pregnant
smokers. Only 2% of SSSP reported no standard con-
tact method although contact was made by specialist
pregnancy advisors.The majority (58%) of SSSP provided training on
smoking in pregnancy during midwifery training at local
hospitals (Table 2). Additionally, 25% of SSSP are in-
volved with training of student midwives. Only 6% of
SSSP did not report being involved with training mid-
wives (Table 2). Almost all (88%) of SSSP reported pro-
moting their pregnancy service. The most popular types
of service promotion included training for midwives/
family doctor practice staff (91%), posters in antenatal
clinics (93%) and posters/flyers elsewhere in the commu-
nity (82%; Table 2).
Service delivery
The most common locations in which SSSP reported
providing smoking cessation support to pregnant women
were in the client’s own home (72%), children’s centres
(72%) and in family doctor practices (71%; Table 3). The
median number of locations used for delivering smoking
cessation support (from a list of 12) was 5 (ranging
from 1 to 9).
On the basis that support may be tailored to each indi-
vidual pregnant woman, we asked which combinations
of behavioural support and nicotine replacement therapy
(NRT) were offered during the year 2010–11 from the
following: single therapy NRT only, dual therapy NRT
only, behavioural support and single therapy NRT, be-
havioural support and dual therapy NRT, and behav-
ioural support only; respondents could select more than
one answer (Table 2). The majority (62%) of services
reported providing psychosocial (behavioural) support
without accompanying NRT to pregnant women. Behav-
ioural support was also offered concomitantly with either
Table 2 Organisation of English Stop Smoking Services for Pregnant women
Percentage n Total*
Service configuration
Support for pregnant women offered via:** Generic Stop Smoking Service 57 69
121
Specialist SSSP 55 67
Midwives employed by maternity unit 12 15
Healthy lifestyles’ service 2 2
Funded by “payment by results” 7 8 121
Specific pregnancy budget 31 34 109
Have current specialist pregnancy advisor in post 76 92 121
Ever had a specialist pregnancy advisor in post 59 17 29†
Substantial changes have taken place at SSSP since March 2011 59 61 104
Identification and referral
Identification of smokers:** Self-reported smoking status only 39 46
118
Exhaled CO only 27 32
Combination of exhaled CO and self-report 18 21
No policy exists/Not sure 9 11
Referral of smokers:** Opt-in 55 44
118Opt-out 37 65
No single policy/Not sure 8 9
Combined exhaled CO and opt-out 20 24 118
Most common referring group: Community midwife 76 89
118
Hospital midwife 17 20
Self-referral 3 4
Family doctor 2 2
Other 2 2
Clinician 1 1
Nurse 0 0
Health visitor 0 0
Children’s centre staff 0 0
Pregnancy outreach workers 0 0
Engaging with pregnant women
Staff member initially engaging with referred women: Specialist stop smoking in pregnancy advisor 45 53
118
Administrative staff 25 29
Specialist stop smoking in pregnancy manager/lead 13 15
Stop Smoking manager/advisor 12 14
Any staff member 3 3
Other 3 3
Midwife 1 1
Nurse 0 0
Pharmacist 0 0
Mode of contact for engaging with referred women: Telephone call 88 104
118
Letter 6 7
Text message 3 3
Face-to-face in clinic 2 2
No standard contact method 2 2
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Table 2 Organisation of English Stop Smoking Services for Pregnant women (Continued)
Email 0 0
Home visit 0 0
Referred women establish contact 0 0
Stage of pregnancy referrals most commonly received in: First trimester 86 61
71††Second trimester 10 7
Third trimester 4 3
Service promotion
Setting in which smoking in pregnancy training provided:** Mandatory training for maternity services midwives 58 68
118
Optional training for maternity services midwives 58 68
Other 33 39
University training for student midwives 25 29
None 6 7
Type of service promotion:** Posters in antenatal clinics 93 100
108
Training for midwives/Family doctor practice staff 91 98
Posters/flyers in community 82 89
Flyers etc. in maternity booking packs 70 76
Television/radio/local press 32 35
Obstetrician meetings 32 34
Other 30 32
Internet including social networking sites 19 20
None 2 2
SSSP, Stop Smoking Service for Pregnant Women; CO, carbon monoxide; NRT, nicotine replacement therapy.
*total relates to number of SSSPs answering any part of that question. **question type allowed for multiple responses. †question was only asked of the 29 SSSP
who said they did not have a specialist smoking in pregnancy advisor in post during 2010–11. ††this question was only asked of the 71 SSSP who said women
were referred more commonly during a particular stage of their pregnancy.
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with a short acting NRT product by 77% and 86% of
services, respectively (Table 3). All respondent services re-
ported providing some form of NRT to pregnant women
and 9% and 10% provided either single or dual therapy
NRT, respectively, to pregnant women without accom-
panying behavioural support. Many SSSP (65%) also re-
ported providing ‘relapse prevention support’. We defined
relapse prevention support as where women were sup-
ported following their cessation treatment programme to
prevent relapse. Around a third (35%) of services provided
smoking cessation support as part of a financial incentive
scheme, defined as providing financial rewards to preg-
nant women upon reaching predefined smoking cessation
targets (Table 3).
The most frequently used types of NRT products
offered were transdermal patches (93%), inhalators (87%)
and mini-lozenges (67%; Table 3). When asked how
NRT was supplied to pregnant women, 43% of services
did so using vouchers to be redeemed at local pharma-
cies, 20% reported NRT was provided by physician pre-
scription, 8% directly supplied NRT to pregnant women
whilst the remaining 28% reported using a combination
of these methods (Table 3). The majority of services alsosaid that exhaled CO testing was routinely used as part
of smoking cessation treatment provided to pregnant
women (89%; Table 3).
The majority (90%) of services reported providing
intensive one-to-one behavioural support to pregnant
women. Of these, 11% provided this solely in clinics,
26% provided this solely in women’s homes and the
remaining 63% provided one-to-one support in both
clinics and women’s homes. The median percentage of
pregnant women accessing one-to-one support in the
home was 54% compared to 50% for clinic-based sup-
port. Home visits took on average more time than
clinic-based visits (mode time categories 30–60 minutes
and 20–30 minutes, respectively; Table 4). The median
number of different behavioural support types from the
list of 10 (Table 4) selected by services was 4 (range 1–6).
Discussion
The study reported here is the first to describe how
smoking cessation support is offered to pregnant women
across England. Despite being relatively new, these ser-
vices are well established in all parts of the country and
offer a range of interventions from a variety of local
community locations; the majority offer support to
Table 3 Service delivery models employed by English Stop Smoking Services for Pregnant women
Percentage n Total*
Location of smoking cessation support for pregnant women:** Women's homes 73 80
110
Children’s centres 73 80
Family doctor practices 72 79
Clinics 69 76
Health centres 63 69
Other community venues 59 65
Pharmacies 56 62
Other 10 11
Military 7 8
Mobile units 6 7
Prisons 5 5
Dentists 5 5
Types of intervention provided:** Behavioural support and dual NRT 86 95
110
Behavioural support and single NRT 77 85
Relapse prevention 65 72
Behavioural support only 62 68
Financial incentive schemes 35 39
Dual NRT only (no behavioural support) 10 11
Single NRT only (no behavioural support) 9 10
Most frequently used NRT products:** Transdermal patches 93 79
85†
Inhalator 87 74
Mini-lozenges 67 57
Gums 47 40
Mouth spray 13 11
Lozenges 12 10
Microtabs 11 9
Nasal spray 2 2
Mode of NRT supply:** Voucher to be redeemed at local pharmacy only 43 47
108†
Combination of supply methods 28 31
Physician prescription only 20 22
Direct supply only 8 9
Routine use of CO monitoring during smoking cessation treatment 89 98 110
Self-help materials provided to pregnant women 64 70 110
Types of self-help materials provided to pregnant women:** Booklet/leaflet 97 68
70††
Website 57 40
Generic text message advice 21 15
DVD 20 14
Other 9 6
Application on mobile phone/device 4 3
Generic email advice 3 2
Agreement with statement ‘self-help materials are effective in helping
women to stop smoking during pregnancy’:
Not at all 3 2
72††
A little 29 21
Moderately 49 35
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Table 3 Service delivery models employed by English Stop Smoking Services for Pregnant women (Continued)
Very much 14 10
Extremely 6 4
Agreement with statement ‘self-help materials should be included in
routine care for smoking cessation during pregnancy’:
Not at all 0 0
70††
A little 10 7
Moderately 29 20
Very much 39 27
Extremely 23 16
SSSP, Stop Smoking Service for Pregnant Women; CO, carbon monoxide; NRT, nicotine replacement therapy.
*total relates to number of SSSPs answering any part of that question. **question type allowed for multiple responses. †these questions were only asked of the
110 SSSP who said they offered NRT to pregnant women. ††question was only asked of the subset of 72 SSSP who reported providing pregnant women with
smoking cessation self-help materials.
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many smoking cessation services are specifically dedi-
cated to pregnant women. England offers smoking cessa-
tion support to help any pregnant woman motivated to
quit which is free at the point of use and our survey
demonstrates the diversity of support currently offered.
The services described provide a potentially useful model
for other countries.
Smokers in the UK are estimated to be four times
more likely to quit if they use a Stop Smoking Service
[22], however, around only 15% of pregnant women who
smoke access these services in England [20]. We found
that only one third of services employed ‘opt-out’ refer-
ral pathways. These involve antenatal services passing
on the details of any pregnant woman who smokes to
Stop Smoking Services and, although such referral path-
ways are recommended in national guidance,[16] further
evidence for their effectiveness is needed. One recent
UK study found identifying pregnant smokers using
carbon monoxide testing and referring to SSSP via an
opt-out pathway increased referrals, but not successfulTable 4 Proportion of pregnant women accessing behavioura
pregnant women
Number SSSP providing
support type
Media
accessing
Clinic based one-to-one support 97
Home based one-to-one support 81
Telephone support 64
Couple/family sessions 48
Drop-in sessions 47
Text message support 23
Open group sessions 16
Other 8
Closed group sessions 6
Email support 2
SSSP, Stop Smoking Services for Pregnant women; IQR, Interquartile Range.
*n relates to number of services that selected that time category option.
**total relates to number of services answering any part of question.four week CO-validated quits [23]. Additional methods
to maximise uptake of services include providing train-
ing at mandatory midwifery events to keep smoking
cessation on their agenda [12,24,25] and providing pro-
motional materials such as posters and flyers in both
hospital and community locations. Although diverse
methods for engaging pregnant smokers in support from
SSSP appear to be widely used, the relative effectiveness
of these has yet to be determined.
Self-reported smoking status is documented as poten-
tially being unreliable in the general population where
non-smoking tends to be over reported [26,27] and, due
to the added social stigma of smoking in pregnancy, this
may also be problematic for obtaining smoking status at
this time too [28,29]. Although exhaled breath carbon
monoxide testing is a practical method for validating
smoking status [29], less than half of SSSP use exhaled
CO to identify pregnant women which suggests the need
for this practice to be recognised more widely by both
service managers and at NHS Acute Trusts responsible
for maternity care.l support types across stop smoking services for
n (IQR) percentage women
support type across all SSSP
Mode time category per
session in minutes (n)*
Total**
50 (20–80) 20-30 (42)
108
54 (15–75) 30-60 (40)
7 (3–15) 10-20 (11)
8 (4–14) 30-60 (15)
10 (4–20) 20-30 (10)
5 (2–10) <5 (3)
5 (1–5) 10-20 (1); 20–30 (1)
7 (3–13) 10-20 (4)
4 (2–5) 30-60 (1)
3 .
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during pregnancy, although the consensus is that harm
is reduced compared to maternal smoking [30,31]. Con-
sistent with findings from a qualitative study of three
UK Stop Smoking Services [25], our survey showed that
all responding services in England offer NRT to pregnant
women as part of their smoking cessation treatment.
However, there is currently insufficient evidence to con-
clude whether NRT in pregnancy is either effective or safe
[3,32,33], as demonstrated in a recent meta-analysis of six
randomised controlled trials of NRT use for smoking
cessation in pregnancy [34]. We found that transdermal
patches were the most frequently provided form of NRT,
despite previous work showing patch compliance to be
low in pregnant women [32,35].
Most of the literature evaluating NRT use in pregnancy
relates to single therapy NRT [34,36] yet the majority
(86%) of services have reported offering higher-dose, dual
therapy NRT which involves using both a transdermal
patch and a short acting NRT formulation concurrently.
Further research is needed to evaluate the utility of this
practice. One recent correlation study found dual therapy
NRT to be associated with smoking cessation in women
attending English SSSP [37], although this has yet to be
assessed in a randomised control trial. Around 1 in 10
services also offer NRT products to pregnant women in
the absence of behavioural support. However, there is
strong evidence that intensive behavioural support is
effective for smoking cessation during pregnancy [3],
and the logic of providing an unproven treatment such
as NRT without this is questionable.
Although offering a flexible client-centred service is
generally considered to be key to smoking cessation sup-
port [16,38], there is little evidence underpinning how
this should be done. Most services seem to attempt this
by using a range of methods to engage with pregnant
women who have been referred to the service, providing
smoking cessation support in a number of community
locations and offering a range of behavioural support
types. Almost 90% of services offered intensive one-to-
one support either in the client’s home or clinic setting
and home visits were reported, on average, to take more
time than clinic-based ones resulting, in higher service
delivery costs for these. However, there is no evidence
that home –delivered support is more effective; Brose
et al. reported no significant difference in CO validated
four week abstinence for pregnant women receiving home
visits compared to attending support in specialist clinics
in England [37].
The extent to which financial incentives for smoking
cessation in pregnancy are now being used in England,
is an interesting. A meta-analysis of pooled results by
Lumley et al. from four trials showed financial incentives
for smoking cessation during pregnancy were significantlymore effective than other intervention strategies [3]. All of
these trials took place in the USA and UK national guid-
ance has called for research to establish whether these
types of interventions could be effective if used in the UK
NHS [16]. What appears to have happened in practice is
that a proportion of stop smoking services have added
incentives to their existing service provision despite lim-
ited evidence. Just over a third of services were using these
types of interventions, with many located in one English
region that was piloting their delivery over a two year
period. This raises important implications for future re-
search as evidence of their effectiveness in routine care
could inform future service developments both in the UK
and elsewhere.
This study had a number of strengths as well as limita-
tions. We received a high response rate of 86%, suggest-
ing that the results are likely to be representative of
SSSP in England. In addition, responding and non-
responding services did not differ in terms of quit rates
or deprivation score, offering further reassurance about
the representativeness of findings. Responding services
were significantly ‘larger’, i.e. more pregnant women
attended and set quit dates and stopped smoking using
these services, compared with non-responding ones.
This may reflect that larger services were better able to
find a member of staff with the time to complete the
survey. To the extent that these differences may have in-
fluenced the results of the survey, the comprehensive-
ness of models of service delivery may have been
overestimated. A potential limitation of the study is that
data are self-reported and as such may be unreliable. We
do not anticipate, however, that service managers would
have been motivated to provide incorrect information.
Inaccuracies may have arisen through misinterpretation
of the online survey, however, we addressed this by pro-
viding ‘pop-up’ definitions where, appropriate. Addition-
ally, at the outset, we recognised potential difficulties in
summarising complex service models in survey ques-
tions and categories and attempted, address this with
thorough piloting.
Conclusions
This work illustrates that the NHS SSSP provide flexible
client-centred services to help pregnant women stop
smoking in England, and identifies a number of ele-
ments of service provision that merit further research
and evaluation.
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